Skip to main content
SpringerLink
Log in

CASE REPORT: Tolcapone-Related Fulminant Hepatitis

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Waters CH, Kurth M, Bailey P, Shulman LM, LeWitt P, Dorflinger E, Deptula D, Pedder S: Tolcapone in stable Parkinson's disease: Efficacy and safety of long term treatment. Neurology 49:665-671, 1997

    Google Scholar 

  2. Baas H, Beiske AG, Ghika J, Jackson M, Oertel WH, Poewe W, Ransmayr G: COMT inhibition with tolcapone reduces the “wearing-off” phenomenon and levodopa requirements in fluctuating parkinsonian patients. J Neurol Neurosurg Psychiatry 63:421-428, 1997

    Google Scholar 

  3. Rajput AH, Martin W, Saint Hilaire M-H, Dorflinger E, Pedder S: Tolcapone improves motor function in parkinsonian patients with the “wearing-off” phenomenon: A double blind, randomized, placebo-controlled trial. Neurology 49:1066-1071, 1997

    Google Scholar 

  4. Assal F, Spahr L, Hadengue A, Rubbia-Brandt L, Burkhard P: Tolcapone and fulminant hepatitis. Lancet 352:958, 1998 (letter).

    Google Scholar 

  5. McCaul TF, Fagan EA, Tovey G, Portmann B, Williams R, Zuckerman AJ: Fulminant hepatitis. An ultrastructural study. J Hepatol 2:276-290, 1986

    Google Scholar 

  6. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: Definitions and causes. Semin Liv Dis 6(2):97-106, 1986

    Google Scholar 

  7. Lebrec D, Nouel O, Bernuau J, Rueff B, Benhamou JP: Portal hypertension in fulminant viral hepatitis. Gut 21:962-964, 1980

    Google Scholar 

  8. Danan G: Consensus meeting on causality assessment of drug-induced liver injury. J Hepatol 7:132-136, 1988

    Google Scholar 

  9. Maria VAJ, Victorino RMM: Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 26:664-669, 1997

    Google Scholar 

  10. Nissinen E, Kaheinen P, Penttila KE, Kaivola J, Linden IB: Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production. Eur J Pharmacol 340:287-294, 1997

    Google Scholar 

  11. Pessayre D: Role of reactive metabolites in drug-induced hepatitis. J Hepatol 23(suppl 1):16-24, 1995

    Google Scholar 

  12. Fromenty B, Pessayre D: Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther 67(1):101-154, 1995

    Google Scholar 

  13. Sobaniec-Lotowska ME: Effects of long-term administration of the antiepileptic drug sodium valproate upon the ultrastructure of hepatocytes in rats. Exp Toxic Pathol 49:225-232, 1997

    Google Scholar 

  14. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD: Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1:1269, 1989

    Google Scholar 

  15. Swerdlow RH, Parks JK, Miller SW, Tuttle JB, Trimmer PA, Sheehan JP, Bennett JP, Davis RE, Parker WD: Origin and functional consequences of the complex I defect in Parkinson's disease. Ann Neurol 40(4):663-671, 1996

    Google Scholar 

  16. Factor SA, Ortof E, Dentinger MP, Mankes R, Barron KD: Platelet morphology in Parkinson's disease: An electron microscopic study. J Neurol Sci 122:84-89, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Department of Neurology, and Division of Clinical Pathology, University Hospital, Geneva, Switzerland

    Laurent Spahr, Laura Rubbia-Brandt, Pierre R. Burkhard, Frédéric Assal & Antoine Hadengue

Authors
  1. Laurent Spahr
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Laura Rubbia-Brandt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pierre R. Burkhard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Frédéric Assal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Antoine Hadengue
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spahr, L., Rubbia-Brandt, L., Burkhard, P.R. et al. CASE REPORT: Tolcapone-Related Fulminant Hepatitis. Dig Dis Sci 45, 1881–1884 (2000). https://doi.org/10.1023/A:1005549304404

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005549304404

Search

Navigation